Jianguo Cao

This inventor holds 84 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D417-14). Top assignees: Samumed, LLC, Calcimedica, Inc., Targegen, Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianguo Cao. Retrieved from https://idiyas.com/inventor/jianguo-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 84 (Patent Applications = 16)

% Patents Active = 89.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 6.0

ph-index = 12

Forward Citations = 717(Granted Patents)

Forward Citations (Not Self Cited) = 466(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

San Diego, CA (US) (2008 - 2023)
La Jolla, CA (US) (2024)

Company Filing History:

Biosplice Therapeutics, Inc.

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Isoquinolin-3-yl Carboxamides

Intracellular Calcium Modulation

Therapeutic Uses

5-Heteroaryl Substituted Indazoles

Diazanaphthalen-3-yl Carboxamides

3H-Imidazo[4,5-B]Pyridine

1H-Pyrazolo[4,3-B]Pyridine

1H-Indazol-3-yl Compounds

1H-Pyrazolo[3,4-C]Pyridines

1H-Pyrrolo[2,3-C]Pyridines

5-Membered Heteroaryl Compounds

84 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281097 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2025-04-21),

2. 11905248 - Compounds that modulate intracellular calcium (2024-02-20),

3. 11713320 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2023-08-01),

4. 11673881 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-06-13),

5. 11548872 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-01-10),

6. 11174244 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2021-11-16),

7. 10947217 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2021-03-16),

8. 10934297 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2021-03-02),

9. 10744128 - 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof (2020-08-18),

10. 10703748 - Diazanaphthalen-3-yl carboxamides and preparation and use thereof (2020-07-07),

11. 10703722 - Compounds that modulate intracellular calcium (2020-07-07),

12. 10653688 - 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof (2020-05-19),

13. 10604512 - 3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof (2020-03-31),

14. 10596154 - 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof (2020-03-24),

15. 10556885 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2020-02-11),

As a specialist in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with a well-crafted article about inventor Jianguo Cao. Let's delve into his remarkable journey of innovation and impact in the world of technology.

Title: Jianguo Cao: A Pioneer in Technology Innovation

Introduction:

Jianguo Cao, a renowned inventor based in San Diego, CA (US), is a trailblazer with a passion for innovation and a relentless drive to create a positive impact through his groundbreaking inventions. With an impressive portfolio of 82 patents, Jianguo Cao stands out as a true visionary in the realm of technology.

Latest Patents:

Among his latest patents are the "5-heteroaryl substituted indazole-3-carboxamides" and "Isoquinolin-3-yl carboxamides." These patents showcase Jianguo Cao's innovative approach in developing compounds for treating various diseases and pathologies, particularly those related to the activation of Wnt pathway signaling and neurological conditions associated with DYRK1A overexpression.

Career Highlights:

Jianguo Cao has made significant contributions to the field of technology through his work at companies like Samumed, LLC, and Calcimedica, Inc. His expertise and ingenuity have led to the development of novel solutions that have the potential to revolutionize the treatment of complex disorders and diseases.

Collaborations:

Throughout his career, Jianguo Cao has collaborated with esteemed professionals in the industry, including Chandramouli Chiruta and Sunil Kumar KC. These collaborations have not only enriched his work but have also fostered a culture of innovation and shared knowledge within the tech community.

Conclusion:

In conclusion, Jianguo Cao's unwavering dedication to innovation and his commitment to creating positive change through his inventions make him a true pioneer in the world of technology. His exemplary work serves as an inspiration to aspiring inventors and underscores the transformative power of inventive thinking and perseverance in driving meaningful progress in society.

Profile summary based on public USPTO records.